🍽️ epicor

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations   |   βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of epicor On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Increases

Bacteria Impacted by epicor

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Clostridiales Family XI. Incertae Sedis family Increases ⚗️ Source Study
Akkermansiaceae family Increases 👪 Source Study
Bacteroidaceae family Increases 📓 Source Study
Prevotellaceae family Increases 📓 Source Study
Verrucomicrobiaceae family Increases 📓 Source Study
Alloprevotella genus Increases 👶 Source Study
Bacteroides genus Increases 👶 Source Study
Brevifollis genus Increases 👶 Source Study
Fucophilus genus Increases 👶 Source Study
Hallella genus Increases 👶 Source Study
Haloferula genus Increases 👶 Source Study
Hoylesella genus Increases 👶 Source Study
Leyella genus Increases 👶 Source Study
Luteolibacter genus Increases 👶 Source Study
Massiliprevotella genus Increases 👶 Source Study
Mediterranea genus Increases 👶 Source Study
Metaprevotella genus Increases 👶 Source Study
Paraprevotella genus Increases 👶 Source Study
Persicirhabdus genus Increases 👶 Source Study
Phocaeicola genus Increases 👶 Source Study
Prevotella genus Increases 👶 Source Study
Prevotellamassilia genus Increases 👶 Source Study
Prosthecobacter genus Increases 👶 Source Study
Pseudoprevotella genus Increases 👶 Source Study
Roseimicrobium genus Increases 👶 Source Study
Segatella genus Increases 👶 Source Study
Sulfuriroseicoccus genus Increases 👶 Source Study
Verrucomicrobium genus Increases 👶 Source Study
Anaerorhabdus genus Increases 👶 Source Study
Akkermansia genus Increases 👪 Source Study
Akkermansia genus Increases 📓 Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Akkermansia no rank Increases 👶 Source Study
unclassified Prevotellaceae no rank Increases 👶 Source Study
Tissierellales order Increases ⚗️ Source Study
Bacteroidales order Increases 👪 Source Study
Verrucomicrobiales order Increases 👪 Source Study
Anaerococcus octavius species Increases ⚗️ Source Study
Finegoldia sp. S9 AA1-5 species Increases ⚗️ Source Study
Finegoldia magna species Increases ⚗️ Source Study Infectious bacteria
Paraprevotella clara species Increases ⚗️ Source Study
Akkermansia glycaniphila species Increases 👶 Source Study
Akkermansia muciniphila species Increases 👶 Source Study
Akkermansia sp. species Increases 👶 Source Study
Anaerococcus sp. 8404299 species Increases ⚗️ Source Study
Anaerococcus vaginalis species Increases ⚗️ Source Study
Akkermansia muciniphila species Increases 📓 Source Study
Akkermansia muciniphila ATCC BAA-835 strain Increases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Increases ⚗️ Source Study

Impact of epicor on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.2 -0.2
ADHD 0.6 0.2 2
Allergic Rhinitis (Hay Fever) 0.7 -0.7
Allergies 0.6 0.6 0
Allergy to milk products 0.6 0.4 0.5
Alzheimer's disease 0.4 1.6 -3
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.4 1.4 -2.5
Ankylosing spondylitis 1 1 0
Anorexia Nervosa 0.2 0.2
Asthma 1 1.2 -0.2
Atherosclerosis 0.4 0.2 1
Atrial fibrillation 0.6 0.2 2
Autism 2.3 1.3 0.77
Bipolar Disorder 0.2 0.4 -1
Brain Trauma 1.3 1.3
Carcinoma 0.4 0.6 -0.5
Celiac Disease 0.8 0.2 3
Cerebral Palsy 0.4 0.6 -0.5
Chronic Fatigue Syndrome 0.2 1.1 -4.5
Chronic Kidney Disease 0.4 -0.4
Chronic Lyme 0.2 0.2
Chronic Obstructive Pulmonary Disease (COPD) 0.2 -0.2
Chronic Urticaria (Hives) 0.6 0.6
Coagulation / Micro clot triggering bacteria 0.2 -0.2
Colorectal Cancer 0.6 1 -0.67
Constipation 0.8 0.8 0
Coronary artery disease 0.2 -0.2
COVID-19 2.4 0.8 2
Crohn's Disease 1 1.3 -0.3
cystic fibrosis 0.2 0.2
Depression 2.7 2.4 0.13
Eczema 0.9 -0.9
Endometriosis 0.2 0.4 -1
Epilepsy 1.4 1 0.4
Fibromyalgia 0.2 0.2
Functional constipation / chronic idiopathic constipation 1 1 0
gallstone disease (gsd) 0.2 -0.2
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.2 0.2 0
Generalized anxiety disorder 0.5 0.5
giant cell arteritis 0.3 -0.3
Glioblastoma 0.2 0.2
Gout 0.9 -0.9
Graves' disease 1.3 -1.3
Halitosis 0.4 -0.4
Hashimoto's thyroiditis 0.4 0.6 -0.5
Hidradenitis Suppurativa 0.4 -0.4
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.4 -0.4
hypercholesterolemia (High Cholesterol) 0.4 0.2 1
hyperglycemia 1.2 0.3 3
Hyperlipidemia (High Blood Fats) 1 -1
hypertension (High Blood Pressure 0.8 1 -0.25
Hypoxia 0.2 0.6 -2
IgA nephropathy (IgAN) 0.2 0.2
Inflammatory Bowel Disease 1 0.4 1.5
Insomnia 1 0.8 0.25
Intelligence 0.8 0.8
Intracranial aneurysms 0.2 -0.2
Irritable Bowel Syndrome 0.8 1.4 -0.75
Liver Cirrhosis 0.8 1 -0.25
Long COVID 2.1 2.2 -0.05
Lung Cancer 0.4 0.4
ME/CFS with IBS 0.2 0.2
ME/CFS without IBS 0.2 0.2
Metabolic Syndrome 2 1.8 0.11
Mood Disorders 2.8 3.4 -0.21
multiple chemical sensitivity [MCS] 0.4 -0.4
Multiple Sclerosis 0.4 1.6 -3
Multiple system atrophy (MSA) 0.8 -0.8
Neuropathy (all types) 0.4 -0.4
neuropsychiatric disorders (PANDAS, PANS) 0.6 -0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.6 0.2 7
Obesity 1.4 1.1 0.27
obsessive-compulsive disorder 0.8 0.2 3
Osteoarthritis 0.2 -0.2
Osteoporosis 0.8 0.8 0
Parkinson's Disease 1 1.9 -0.9
Polycystic ovary syndrome 0.4 1.4 -2.5
Psoriasis 1.3 0.6 1.17
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.2 2 -0.67
Schizophrenia 0.2 1.7 -7.5
scoliosis 0.2 0.2
Sjögren syndrome 0.4 0.2 1
Sleep Apnea 0.2 0.2
Small Intestinal Bacterial Overgrowth (SIBO) 0.2 -0.2
Stress / posttraumatic stress disorder 0.6 0.6 0
Systemic Lupus Erythematosus 1 1.6 -0.6
Tic Disorder 0.8 0.2 3
Tourette syndrome 0.2 0.6 -2
Type 1 Diabetes 0.2 1 -4
Type 2 Diabetes 1.4 1.6 -0.14
Ulcerative colitis 3 0.4 6.5
Unhealthy Ageing 0.6 0.2 2

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)